We also analyzed published data sets for patients with various types of cancer such as gastric adenocarcinoma (26), lung adenocarcinoma (27), breast cancer (28), renal cell carcinoma (29), pancreatic adenocarcinoma (30), and glioblastoma (31) to determine the relationship between viperin expression and the outcomes of the patients. Here, RSAD2 is linked to breast cancer.